Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $494

Benzinga · 2d ago
Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $412 to $494.